AMOROSO, Rosa
 Distribuzione geografica
Continente #
NA - Nord America 11.185
EU - Europa 7.043
AS - Asia 6.233
Continente sconosciuto - Info sul continente non disponibili 936
SA - Sud America 673
AF - Africa 98
OC - Oceania 9
Totale 26.177
Nazione #
US - Stati Uniti d'America 10.755
SG - Singapore 2.290
CN - Cina 1.660
IT - Italia 1.471
RU - Federazione Russa 1.268
IE - Irlanda 791
TR - Turchia 791
UA - Ucraina 728
SE - Svezia 686
VN - Vietnam 589
BR - Brasile 550
GB - Regno Unito 541
FR - Francia 453
IN - India 414
DE - Germania 376
CA - Canada 237
FI - Finlandia 182
PL - Polonia 162
HK - Hong Kong 91
AT - Austria 75
BD - Bangladesh 71
LT - Lituania 71
ES - Italia 61
JP - Giappone 57
MX - Messico 57
NL - Olanda 47
PK - Pakistan 39
KR - Corea 35
AR - Argentina 34
BE - Belgio 34
ZA - Sudafrica 32
CZ - Repubblica Ceca 31
IQ - Iraq 26
IL - Israele 25
ID - Indonesia 24
CR - Costa Rica 23
VE - Venezuela 22
CO - Colombia 21
EC - Ecuador 18
JM - Giamaica 18
HN - Honduras 17
TT - Trinidad e Tobago 16
GT - Guatemala 15
MY - Malesia 15
PH - Filippine 15
CL - Cile 13
DZ - Algeria 13
AE - Emirati Arabi Uniti 11
GR - Grecia 11
MA - Marocco 11
SA - Arabia Saudita 11
KE - Kenya 10
TW - Taiwan 10
SV - El Salvador 9
AU - Australia 8
CW - ???statistics.table.value.countryCode.CW??? 8
EE - Estonia 8
NI - Nicaragua 8
PR - Porto Rico 8
PT - Portogallo 8
IR - Iran 7
PE - Perù 7
AL - Albania 6
CH - Svizzera 6
EG - Egitto 6
ET - Etiopia 6
HR - Croazia 6
JO - Giordania 6
UZ - Uzbekistan 6
BG - Bulgaria 5
DO - Repubblica Dominicana 5
GP - Guadalupe 4
KZ - Kazakistan 4
LB - Libano 4
NP - Nepal 4
PY - Paraguay 4
SC - Seychelles 4
SY - Repubblica araba siriana 4
TN - Tunisia 4
AZ - Azerbaigian 3
BB - Barbados 3
DK - Danimarca 3
OM - Oman 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
TH - Thailandia 3
YE - Yemen 3
BH - Bahrain 2
CY - Cipro 2
DM - Dominica 2
EU - Europa 2
HU - Ungheria 2
KG - Kirghizistan 2
KH - Cambogia 2
LY - Libia 2
PA - Panama 2
UY - Uruguay 2
ZW - Zimbabwe 2
A2 - ???statistics.table.value.countryCode.A2??? 1
Totale 25.229
Città #
Singapore 1.715
San Jose 1.186
Chandler 984
Jacksonville 836
Dublin 778
Ashburn 766
Dallas 700
Izmir 499
Beijing 395
Council Bluffs 351
Princeton 318
Southend 314
Dearborn 309
Chieti 284
Nanjing 236
Santa Clara 226
Los Angeles 224
The Dalles 222
Ann Arbor 208
Wilmington 195
Ho Chi Minh City 186
Cambridge 164
New York 126
Hanoi 117
Buffalo 108
Kraków 108
Washington 103
Nanchang 102
Tongling 102
Pescara 98
Houston 96
Woodbridge 91
Altamura 80
Hong Kong 78
Moscow 76
Boardman 71
Munich 67
North Bergen 66
Columbus 64
São Paulo 64
Dong Ket 62
Vienna 62
Kocaeli 57
Hebei 55
Atlanta 53
Hefei 53
Rome 53
Milan 50
Kunming 49
Phoenix 49
Warsaw 47
Tianjin 46
Jiaxing 45
Toronto 45
Denver 44
Montreal 44
Vilnius 44
Helsinki 43
Chicago 42
Orem 42
Redondo Beach 42
Shenyang 42
Teramo 41
Tokyo 41
Bosa 40
Brooklyn 40
London 40
Changsha 38
Ottawa 35
Brussels 34
Da Nang 34
Jinan 34
Bologna 32
Chennai 32
Norwalk 30
Agrolândia 27
Frankfurt am Main 27
Stockholm 27
Brno 26
Poplar 26
Ningbo 24
Hangzhou 23
Nuremberg 23
Amsterdam 22
Augusta 22
Rio de Janeiro 22
Seoul 22
Haiphong 21
Mount Pleasant 21
Naples 21
Philadelphia 21
Turku 21
Johannesburg 20
Seattle 20
Guangzhou 19
Boston 18
Mexico City 18
San Francisco 18
Ankara 16
League City 16
Totale 14.794
Nome #
1,3-Asymmetric induction: Highly enantioselective synthesis of α-amino acids via 2,5-trans disubstituted imidazolidin-4-ones 1.254
Valutazione biologica e computazionale di inibitori della Ossido Nitrico Sintasi 264
The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Pancreatic Cancer 219
Effects of dichloroacetate as single agent or in combination with GW6471 and metformin in paraganglioma cells 210
Anticancer Activity of Stilbene-Based Derivatives 208
Inhibition of PPARγ by Natural Compounds as a Promising Strategy in Obesity and Diabetes 208
Synthesis and antibacterial evaluation of oxazolidin-2-ones structurally related to linezolid 205
Synthesis of 2-aryloxypropanoic acids analogues of clofibric acid and assignment of the absolute configuration by 1H NMR spectroscopy and DFT calculations 204
Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-L-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma 198
Synthesis of fibrates analogues and pharmacological evaluation as PPARa agonists 195
Titanium-Promoted Acylation of Sulfonamides to N-Acylsulfonamide PPAR Antagonists 191
Amidine N-sostituite come potenziali inibitori delle Ossido Nitrico Sintasi 190
Emerging Effects of Resveratrol Derivatives in Cells Involved in Oral Wound Healing: A Preliminary Study 189
Novel Phenyldiazenyl Fibrate Analogues as PPAR α/γ/δ Pan-Agonists for the Amelioration of Metabolic Syndrome 189
2-Substituted Benzothiazoles as Antiproliferative Agents: Novel Insights on Structure-Activity Relationships 187
Sintesi di nuovi derivati dell'anello 2-ossazolidinonico: molecole di notevole interesse come ausiliari chirali e come potenziali agenti antimicrobici 186
Progettazione e sintesi di ossazolidinoni a potenziale attività antibatterica 185
Synthesis and structure-activity relationships of fibrate-based analogues inside PPARs 185
Recent developments of amidine-like compounds as selective NOS inhibitors 185
Synthesis, biological activity, and docking studies of novel acetamidines as selective modulators of nitric oxide synthase 184
Valutazione biologica dei derivati dell'acido clofibrico come potenziali ligandi PPARs 183
Asymmetric synthesis of (S)-ibuprofen by esterification with amides of (S)-lactic acid as chiral auxiliaries: experimental and theoretical results 182
Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation 180
Asymmetric Synthesis of Arylpropionic Acids and Aryloxy Acids by Using Lactamides as Chiral Auxiliaries 179
Synthesis and Biological Evaluation of 2-Heteroarylthioalkanoic Acid Analogues of Clofibric Acid as Peroxisome Proliferator-Activated Receptor alfa Agonists 178
Anti-Inflammatory, Antioxidant, and WAT/BAT-Conversion Stimulation Induced by Novel PPAR Ligands: Results from Ex Vivo and In Vitro Studies 176
Cytotoxic effect of a family of Peroxisome Proliferator-Activated Receptor antagonists in colorectal and pancreatic cancer cell lines 175
Discovery of new FXR agonists based on 6-ECDCA binding properties by virtual screening and molecular docking 174
Blocking the Peroxisome Proliferator-Activated Receptor (PPAR): An Overview 174
Synthesis and antiplatelet activity of gemfibrozil chiral analogues 172
Benzothiazole-based N-(phenylsulfonyl)amides as a novel familyof PPARa antagonists 171
Antilipemic agents: synthesis and chemical separation of chiral analogues of gemfibrozil 170
Synthesis of benzothiazolyl-thioalkanoic acids and pharmacological evaluation on PPARa 170
Determinazione della configurazione assoluta di acidi carbossilici a-sostituiti di interesse farmaceutico attraverso spettroscopia NMR 169
Synthesis and biological evaluation of potential Nitric Oxide Synthase inhibitors 169
The Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage In Vitro 168
Resveratrol Derivative Exhibits Marked Antiproliferative Actions, Affecting Stemness in Pancreatic Cancer Cells 167
Druggability profile of stilbene-derived PPAR agonists: Determination of physicochemical properties and PAMPA study 167
Asymmetric synthesis of enantiomerically enriched chiral fibrates, thiols and aminoacids 165
Candida rugosa lipase-catalysed kinetic resolution of 2-substituted-aryloxyacetic esters with dimethylsulfoxide and isopropanol as additives 165
Direct resolution of α-monoalkyl-α-aryloxyacetic acids via ester or imide derivatives 164
Sintesi ed attività antibatterica di 3-cinnamoil e 3-piridinilossazolidin -2-oni 163
Development of a Rapid Mass Spectrometric Determination of AMP and Cyclic AMP for PDE3 Activity Study: Application and Computational Analysis for Evaluating the Effect of a Novel 2-oxo-1,2-dihydropyridine-3-carbonitrile Derivative as PDE-3 Inhibitor 163
Enantiomeric separation of Gemfibrozil chiral analogues by capillary electrophoresis with heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin as chiral selector 162
PPARα agonists based on stilbene and its bioisosteres: Biological evaluation and docking studies 162
Synthesis of diastereomerically enriched 2-bromoesters and their reaction with nucleophiles 161
Synthesis and biological evaluation of gemfibrozil chiral analogs as potential PPARa agonists 160
Chiral analogues of clofibrate: dynamic kinetic resolution via 2-bromoimides 158
4-Substituted prolines, useful reagents in enantioselective synthesis and conformational restraints in bioactive peptidomimetics design 158
Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors 157
Synthesis and antiplatelet activity of thioaryloxyacids analogues of clofibric acid 156
N-acylsulfonamides: synthetic routes and biological potential in medicinal chemistry 155
Synthesis and cytotoxic effects on pancreatic cancer cells of resveratrol analogs 155
Syntesis and pharmacological evaluation of fibrates analogues as cardiovascular agents 154
Fibrate-derived N-(methylsulfonyl)amides with antagonistic properties on PPARa 154
Indazole, Pyrazole, and Oxazole Derivatives Targeting Nitric Oxide Synthases and Carbonic Anhydrases 153
Advancements in the Research of New Modulators of Nitric Oxide Synthases Activity 152
Sulfonimide and Amide Derivatives as Novel PPARα Antagonists: Synthesis, Antiproliferative Activity, and Docking Studies 152
Synthesis and antiplatelet activity of clofibric acid analogues 150
Sintesi e valutazione biologica di analoghi eterociclici del gemfibrozil a potenziale attività cardiovascolare 150
Amidine-Based Bioactive Compounds for the Regulation of Arginine Metabolism 150
Synthesis, biological evaluation and docking studies of N-substituted acetamidines as selective inhibitors of inducible nitric oxide synthase 149
Antiplatelet activity of gemfibrozil chiral analogues 149
Selective Acetamidine-Based Nitric Oxide Synthase Inhibitors: Synthesis, Docking, and Biological Studies 149
Amidine-Based Compounds Affecting L-Arginine Metabolism 148
Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure-Activity Relationship Studies and Target Prediction Analysis 146
Selective inhibition of inducible Nitric Oxide Synthase by derivatives of acetamidine 146
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 146
Fibrate-based N-acylsulphonamides targeting carbonic anhydrases: synthesis, biochemical evaluation, and docking studies 145
Structural development studies of PPARs ligands based on tyrosine scaffold 145
Synthesis of chiral a-substituted β-amino acids starting from 6-alkylperihydropyrimidin-4-ones 144
The anticancer potential of Peroxisome Proliferator-Activated Receptor antagonists 144
Novel aminobenzyl-acetamidine derivative modulate the differential regulation of NOSs in LPS induced inflammatory response: Role of PI3K/Akt pathway 144
Time factor in antiretroviral adherence: analysis of adherence to single-tablet regimens versus multiple-tablet regimens over a 5-year period 143
Synthesis of naphthyl-, quinolin- and anthracenyl analogues of clofibric acid as PPARα agonists 143
Sintesi di analoghi chirali del gemfibrozil 2,5,disostituiti a potenziale attività antiaggregante piastrinica 142
PPAR-γ agonist GL516 reduces oxidative stress and apoptosis occurrence in a rat astrocyte cell line 142
N-Substituted acetamidines and 2-methylimidazole derivatives as selective inhibitors of neuronal nitric oxide synthase 141
Seeking for Non-Zinc-Binding MMP-2 Inhibitors: Synthesis, Biological Evaluation and Molecular Modelling Studies 141
The excitation-contraction coupling on C2C12 skeletal muscle myotubes was modulated by NO-donor ester of gemfibrozil 141
Discovery of gemfibrozil analogues that activate PPARa and enhance the expression of gene CPT1A involved in fatty acids catabolism 140
Synthesis and biological evaluation of new acetamidines as selective inhibitors of Nitric Oxide Synthases 139
Multitarget PPARγ agonists as innovative modulators of the metabolic syndrome 139
Optically active 2-substituted carboxylic acids isosters of fibrates by 2-bromo esters 138
Design, synthesis and biological activity of selective hCAs inhibitors based on 2-(benzylsulfinyl)benzoic acid scaffold 138
Analoghi eterociclici dell’acido clofibrico: sintesi, attività antiaggregante piastrinica e separazione in elettroforesi capillare 136
Development of Fibrates as Important Scaffolds in Medicinal Chemistry 136
Starting a new series of acetamidines as Nitric Oxide Sinthase inhibitors 135
Dynamic kinetic resolution of α-bromoesters containing lactamides as chiral auxiliaries 134
Synthesis and biological evaluation of novel acetamidines as nitric oxide inhibitors 132
Selective Inhibition of iNOS by Benzyl- and Dibenzyl Derivatives of N-(3-Aminobenzyl)acetamidine. 132
Dual-PPAR agonists based on stilbene scaffold: synthesis and biological evaluation 131
Targeting neuronal nitric oxide synthase as a valuable strategy for the therapy of neurological disorders 131
Isosteres of chiral clofibric acid analogs: synthesis, resolution, absolute configuration and HPLC detection of the optical purity 130
Design, synthesis and biological evaluation of aromatase inhibitors based on sulfonates and sulfonamides of resveratrol 130
Azobenzene as Multi-Targeted Scaffold in Medicinal Chemistry 129
Chiral derivatives of clofibrate: direct resolution via ester or imide derivatives 129
Effects of phosphonate isosters of clofibric acid on the biophysical and pharmacological properties of chloride channels belonging to the CLC superfamily 129
Platelet aggregation: synthesis and pharmacological evaluation of clofibric acid analogues 129
Effect of stilbene and chalcone scaffolds incorporation in clofibric acid on PPARα agonistic activity 129
Totale 17.193
Categoria #
all - tutte 95.615
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.615


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022760 0 0 0 0 108 26 37 80 122 38 113 236
2022/20232.795 208 368 190 297 263 548 146 226 356 33 90 70
2023/20241.296 101 46 110 38 80 401 297 28 7 45 15 128
2024/20253.300 143 626 516 76 57 143 196 171 288 166 443 475
2025/20268.069 557 287 960 923 739 417 1.242 494 1.390 558 363 139
2026/20272.244 215 339 346 916 428 0 0 0 0 0 0 0
Totale 26.177